Baebies FINDER/FINDER 1.5

Comprehensive screening platform for early detection of genetic and metabolic disorders in newborns. Delivers rapid, accurate results to support timely clinical intervention and improved patient outcomes.

Comprehensive newborn screening solution combining diagnostic kits, instruments, and software for early detection of rare congenital and metabolic diseases. Enables laboratories to identify genetic predispositions and support pharmacogenetic testing without DNA extraction requirements, streamlining workflow from sample collection to clinical results.

Precision medicine screening platform for early detection of genetic and metabolic disorders in newborns.

Comprehensive newborn screening solution for detecting inborn errors of metabolism and genetic disorders in neonates within the first days of life. Uses fluorometric microplate-based assays for high-sensitivity detection of metabolic conditions such as phenylketonuria.

Newborn screening test for early detection of metabolic, hemoglobin, and functional disorders in newborns. Enables timely clinical intervention to prevent serious health complications and developmental delays. Supports public health programs and hospital-based screening protocols.

Comprehensive screening tests for detection of inborn errors of metabolism in neonates, identifying genetic and metabolic disorders within the first days of life to enable early intervention.

Next-generation sequencing-based screening for over 165 preventable genetic and metabolic diseases in newborns. Enables early detection, diagnosis, and treatment to reduce disease impact using patented All-in-One PCR amplicon capture technology.

Next-generation sequencing-based detection kit screening over 165 preventable genetic and metabolic diseases in newborns. Uses proprietary All-in-One PCR amplicon capture technology combined with NGS for early diagnosis and intervention.

A genetic detection product using high-throughput sequencing technology to screen for over 165 treatable genetic and metabolic diseases in newborns, enabling early detection, diagnosis, and treatment.

Comprehensive testing system for identification of genetic abnormalities and hereditary disorders. Supports clinical diagnosis and prenatal screening applications.

A comprehensive genetic detection product called 'Bekang' that uses proprietary All-in-One ultra-high coverage PCR amplicon capture technology combined with next-generation sequencing to detect over 165 preventable genetic and metabolic diseases in newborns. It enables early detection, early diagnosis, and early treatment to reduce disease burden in infants.

Specialized enzymatic and immunological assays for detecting metabolic disorders including amino acid and organic acid metabolism disorders in newborn screening programs.